Evidence-Based Medicine, JAMA, vol.268, issue.17, pp.2420-2425, 1992. ,
DOI : 10.1001/jama.1992.03490170092032
Evidence based medicine: what it is and what it isn't, BMJ, vol.312, issue.7023, pp.71-73, 1996. ,
DOI : 10.1136/bmj.312.7023.71
Evidence based medicine: Socratic dissent, BMJ, vol.310, issue.6987, pp.1126-1133, 1995. ,
DOI : 10.1136/bmj.310.6987.1126
Essais cliniques : théorie, pratique et critique 4e édition revue et augmentée ,
How to report randomized controlled trials. The CONSORT statement, JAMA: The Journal of the American Medical Association, vol.276, issue.8, p.649, 1996. ,
DOI : 10.1001/jama.276.8.649
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration, Annals of Internal Medicine, vol.134, issue.8, pp.663-94, 2001. ,
DOI : 10.7326/0003-4819-134-8-200104170-00012
Improving the Quality of Reporting of Randomized Controlled Trials, JAMA, vol.276, issue.8, pp.637-646, 1996. ,
DOI : 10.1001/jama.1996.03540080059030
A method for assessing the quality of a randomized control trial, Controlled Clinical Trials, vol.2, issue.1, pp.31-49, 1981. ,
DOI : 10.1016/0197-2456(81)90056-8
Randomisation and baseline comparisons in clinical trials. The Lancet, 20 janv, vol.335, issue.8682, pp.149-53, 1990. ,
Blinding in randomised trials: hiding who got what. The Lancet. 23 févr, pp.696-700, 2002. ,
M??thodologie des essais cliniques de petits effectifs, Th??rapie, vol.59, issue.3, pp.273-282, 2004. ,
DOI : 10.2515/therapie:2004054
Can overall results of clinical trials be applied to all patients? The Lancet, 24 juin, vol.345, issue.8965, pp.1616-1625, 1995. ,
Randomised study of n of 1 trials versus standard practice, BMJ, vol.312, issue.7038, p.1069, 1996. ,
DOI : 10.1136/bmj.312.7038.1069
External validity of randomised controlled trials: « To whom do the results of this trial apply? ». The Lancet. 1 janv, pp.82-93, 2005. ,
N-of-1 trials: individualized medication effectiveness tests, Virtual Mentor VM. janv, vol.15, issue.1, pp.42-47, 2013. ,
Exclusion of elderly people from clinical research: a descriptive study of published reports, BMJ, vol.315, issue.7115, p.1059, 1997. ,
DOI : 10.1136/bmj.315.7115.1059
Evidence-Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages, The Milbank Quarterly, vol.327, issue.6, pp.661-87, 2004. ,
DOI : 10.1001/jama.266.1.93
Which patients may be harmed by good treatments? Lancet. 10 août 1996, pp.351-353 ,
Selection bias and treatment heterogeneity in clinical trials, Statistics in Medicine, vol.47, issue.12, pp.1467-74, 1999. ,
DOI : 10.1002/(SICI)1097-0258(19990630)18:12<1467::AID-SIM149>3.0.CO;2-H
Edoxaban versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.369, issue.22, pp.2093-104, 2013. ,
DOI : 10.1056/NEJMoa1310907
URL : https://hal.archives-ouvertes.fr/hal-00934699
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis, BMC Medical Research Methodology, vol.135, issue.1, p.18, 2006. ,
DOI : 10.1002/bimj.200510157
Limitations of Applying Summary Results of Clinical Trials to Individual Patients, JAMA, vol.298, issue.10, pp.1209-1221, 2007. ,
DOI : 10.1001/jama.298.10.1209
M??thodologie des essais cliniques de petits effectifs, Th??rapie, vol.59, issue.3, pp.273-282, 2004. ,
DOI : 10.2515/therapie:2004054
Users' Guides to the Medical Literature, JAMA, vol.284, issue.10, pp.1290-1296, 2000. ,
DOI : 10.1001/jama.284.10.1290
Determining Optimal Therapy ??? Randomized Trials in Individual Patients, New England Journal of Medicine, vol.314, issue.14, pp.889-92, 1986. ,
DOI : 10.1056/NEJM198604033141406
Gibt es eine deutsche Vorgeschichte der Evidenz-basierten Medizin?, DMW - Deutsche Medizinische Wochenschrift, vol.130, issue.30, pp.1781-1785, 1932. ,
DOI : 10.1055/s-2005-871896
The Self-Controlled and Self-Recorded Clinical Trial for Low-Grade Morbidity, International Journal of Epidemiology, vol.40, issue.6, pp.1438-54, 2011. ,
DOI : 10.1093/ije/dyr026
A clinician's guide for conducting randomized trials in individual patients, CMAJ Can Med Assoc J. 15 sept, vol.139, issue.6, p.497, 1988. ,
N of 1 randomized trials for investigating new drugs, Controlled Clinical Trials, vol.11, issue.2, pp.88-100, 1990. ,
DOI : 10.1016/0197-2456(90)90003-K
N of 1 trials. Practical tools for medication management, Aust Fam Physician. nov, vol.29, issue.11, pp.1108-1120, 2000. ,
Single patient (n-of-1) trials with binary treatment preference, Statistics in Medicine, vol.139, issue.17, pp.2625-2661, 2005. ,
DOI : 10.1002/sim.2132
Regression towards the mean, BMJ. 4 juin, vol.308, issue.6942, p.1499, 1994. ,
N-of-1 Trials in the Medical Literature, Medical Care, vol.49, issue.8, pp.761-769, 2011. ,
DOI : 10.1097/MLR.0b013e318215d90d
Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention, Contemporary Clinical Trials, vol.29, issue.5, pp.705-715, 2008. ,
DOI : 10.1016/j.cct.2008.04.005
Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey, BMJ, vol.312, issue.7037, pp.1016-1036, 1996. ,
DOI : 10.1136/bmj.312.7037.1016
An introduction to the Bayesian analysis of clinical trials, Annals of Emergency Medicine, vol.22, issue.8, pp.1328-1364, 1993. ,
DOI : 10.1016/S0196-0644(05)80119-2
Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials, Journal of Clinical Epidemiology, vol.62, issue.1, pp.13-21, 2009. ,
DOI : 10.1016/j.jclinepi.2008.07.006
Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, Journal of Clinical Epidemiology, vol.50, issue.4, pp.401-411, 1997. ,
DOI : 10.1016/S0895-4356(96)00429-5
Using n-of-1 trials as a clinical tool to improve prescribing, Br J Gen Pract J R Coll Gen Pract. mars, vol.55, issue.512, pp.175-80, 2005. ,
"Me's me and you's you": Exploring patients' perspectives of single patient (n-of-1) trials in the UK, Trials, vol.42, issue.1, p.10, 2007. ,
DOI : 10.1016/0895-4356(89)90035-8
Clinical research for rare disease: Opportunities, challenges, and solutions, Molecular Genetics and Metabolism, vol.96, issue.1, pp.20-26, 2009. ,
DOI : 10.1016/j.ymgme.2008.10.003
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?, Personalized Medicine, vol.8, issue.2, pp.161-73, 2011. ,
DOI : 10.2217/pme.11.7
A Comparison of Four Methods for the Analysis of N-of-1 Trials, PLoS ONE, vol.26, issue.2, p.87752, 2014. ,
DOI : 10.1371/journal.pone.0087752.s004
N-of-1 randomized controlled trials ('N-of-1 trials'): singularly useful in geriatric medicine, Age and Ageing, vol.31, issue.4, pp.227-259, 2002. ,
DOI : 10.1093/ageing/31.4.227
Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials, Contemporary Clinical Trials, vol.30, issue.5, pp.436-481, 2009. ,
DOI : 10.1016/j.cct.2009.04.001
N-of-1 Trials of Expensive Biological Therapies<subtitle>A Third Way?</subtitle>, Archives of Internal Medicine, vol.168, issue.10, p.1030, 2008. ,
DOI : 10.1001/archinte.168.10.1030
Using N-of-1 Trials to Improve Patient Management and Save Costs, Journal of General Internal Medicine, vol.117, issue.6, pp.906-919, 2010. ,
DOI : 10.1007/s11606-010-1352-7
Are N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience, Value in Health, vol.11, issue.1, pp.97-109, 2008. ,
DOI : 10.1111/j.1524-4733.2007.00218.x
The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis, J Rheumatol. janv, vol.31, issue.1, pp.140-149, 2004. ,
Improvement of Apathy After Levofloxacin Treatment, The Neurologist, vol.18, issue.3, pp.146-154, 2012. ,
DOI : 10.1097/NRL.0b013e318251eb23
Do Individualized Medication Effectiveness Tests (N-of-1 Trials) Change Clinical Decisions About Which Drugs to Use for Osteoarthritis and Chronic Pain?, American Journal of Therapeutics, vol.12, issue.1, pp.92-99, 2005. ,
DOI : 10.1097/00045391-200501000-00012
An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder, PEDIATRICS, vol.117, issue.6, pp.2040-2046, 2006. ,
DOI : 10.1542/peds.2005-1328
Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol, Chronic Respiratory Disease, vol.1, issue.2, pp.63-72, 2004. ,
DOI : 10.1191/1479972304cd028oa
Testing nicotine gum for ulcerative colitis patients, Digestive Diseases and Sciences, vol.310, issue.7, pp.827-859, 1990. ,
DOI : 10.1007/BF01536795
A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis & Rheumatism, vol.38, issue.11, pp.1852-1861, 1996. ,
DOI : 10.1002/art.1780391111
Lessons learned combining N-of-1 trials to assess fibromyalgia therapies, J Rheumatol. oct, vol.33, issue.10, pp.2069-77, 2006. ,
Pathogenesis of Raynaud's phenomenon, Rheumatology, vol.44, issue.5, pp.587-96, 2005. ,
DOI : 10.1093/rheumatology/keh552
Mechanisms of Raynaud's disease, Vascular Medicine, vol.10, issue.4, pp.293-307, 2005. ,
DOI : 10.1191/1358863x05vm639ra
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis Disponible sur, Nat Rev Rheumatol, vol.6, issue.8, 2010. ,
Vascular function in systemic sclerosis, Current Opinion in Rheumatology, vol.12, issue.6, pp.527-560, 2000. ,
DOI : 10.1097/00002281-200011000-00009
Geographic variation in the prevalence of Raynaud's phenomenon, J Rheumatol. janv, vol.20, issue.1, pp.70-76, 1993. ,
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review, Seminars in Arthritis and Rheumatism, vol.37, issue.4, pp.223-258, 2008. ,
DOI : 10.1016/j.semarthrit.2007.05.003
Risk factors for Raynaud's phenomenon in the workforce, Arthritis Care & Research, vol.52, issue.Suppl 1, pp.898-904, 2012. ,
DOI : 10.1002/acr.21615
Oral vasodilators for primary Raynaud's phenomenon, Cochrane Database Syst Rev, issue.2, p.6687, 2008. ,
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. Rheumatology. 2 janv, pp.145-50, 2005. ,
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis, Arthritis & Rheumatism, vol.242, issue.8, pp.1841-1848, 2001. ,
DOI : 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8
Sildenafil Increases Digital Skin Blood Flow During All Phases of Local Cooling in Primary Raynaud's Phenomenon, Clinical Pharmacology & Therapeutics, vol.260, issue.5, pp.813-822, 2012. ,
DOI : 10.1038/clpt.2011.302